Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Risk of Ocular Adverse Events with Taxane Based Chemotherapy

Mohit Sodhi, Sonia N. Yeung, David Maberley, Frederick Mikelberg, Mahyar Etminan
doi: https://doi.org/10.1101/2022.02.15.22270863
Mohit Sodhi
1Collaboration for Epidemiology of Ocular Diseases (CEPOD), Department of Ophthalmology and Visual Sciences, Faculty of Medicine, University of British Columbia, Vancouver, Canada
2Faculty of Medicine, University of British Columbia, Vancouver, Canada
MSc, MD (candidate)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonia N. Yeung
1Collaboration for Epidemiology of Ocular Diseases (CEPOD), Department of Ophthalmology and Visual Sciences, Faculty of Medicine, University of British Columbia, Vancouver, Canada
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Maberley
3Department of Ophthalmology, Faculty of Medicine, University of Ottawa, Ottawa, Canada
MD, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederick Mikelberg
1Collaboration for Epidemiology of Ocular Diseases (CEPOD), Department of Ophthalmology and Visual Sciences, Faculty of Medicine, University of British Columbia, Vancouver, Canada
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahyar Etminan
1Collaboration for Epidemiology of Ocular Diseases (CEPOD), Department of Ophthalmology and Visual Sciences, Faculty of Medicine, University of British Columbia, Vancouver, Canada
4Department of Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada
PharmD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: etminanm{at}mail.ubc.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2022.02.15.22270863
History 
  • February 17, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Mohit Sodhi, MSc, MD (candidate)1,2,
  2. Sonia N. Yeung, MD, PhD1,
  3. David Maberley, MD, MSc3,
  4. Frederick Mikelberg, MD1 and
  5. Mahyar Etminan, PharmD MSc1,4,*
  1. 1Collaboration for Epidemiology of Ocular Diseases (CEPOD), Department of Ophthalmology and Visual Sciences, Faculty of Medicine, University of British Columbia, Vancouver, Canada
  2. 2Faculty of Medicine, University of British Columbia, Vancouver, Canada
  3. 3Department of Ophthalmology, Faculty of Medicine, University of Ottawa, Ottawa, Canada
  4. 4Department of Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada
  1. ↵*Corresponding Author: Mahyar Etminan PharmD, MSc
    , Associate Professor of Ophthalmology and Visual Sciences | Faculty of Medicine, The University of British Columbia | The Eye Care Centre, Room 323-2550 Willow Street, Vancouver BC, V5Z 3N9, Phone 604-875-4725 | Fax 604-875-4663, Email: etminanm{at}mail.ubc.ca
Back to top
PreviousNext
Posted February 17, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Risk of Ocular Adverse Events with Taxane Based Chemotherapy
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Risk of Ocular Adverse Events with Taxane Based Chemotherapy
Mohit Sodhi, Sonia N. Yeung, David Maberley, Frederick Mikelberg, Mahyar Etminan
medRxiv 2022.02.15.22270863; doi: https://doi.org/10.1101/2022.02.15.22270863
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Risk of Ocular Adverse Events with Taxane Based Chemotherapy
Mohit Sodhi, Sonia N. Yeung, David Maberley, Frederick Mikelberg, Mahyar Etminan
medRxiv 2022.02.15.22270863; doi: https://doi.org/10.1101/2022.02.15.22270863

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Ophthalmology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)